E-submission
Search
- Page Path
- HOME > Search
Original Article
- Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis
- Alaa Salah Jumaah, Hawraa Sahib Al-Haddad, Mais Muhammed Salem, Katherine Ann McAllister, Akeel Abed Yasseen
- J Pathol Transl Med. 2021;55(3):202-211. Published online April 14, 2021
- DOI: https://doi.org/10.4132/jptm.2021.02.19
- 11,939 View
- 242 Download
- 16 Web of Science
- 18 Crossref
-
Abstract
PDF
Supplementary Material - Background
Loss of mismatch repair (MMR) occurs frequently in endometrial carcinoma (EC) and is an important prognostic marker. However, the frequency of MMR deficiency (D-MMR) in EC remains inconclusive. This systematic review and meta-analysis addressed this inconsistency and evaluated related clinicopathology.
Methods
Electronic databases were searched for articles: PubMed, Science Direct, Web of Science, EMBASE, and the Wiley Online Library. Data were extracted from 25 EC studies of D-MMR to generate a clinical dataset of 7,459 patients. A random-effects model produced pooled estimates of D-MMR EC frequency with 95% confidence interval (CI) for meta-analysis.
Results
The overall pooled proportion of D-MMR was 24.477% (95% CI, 21.022 to 28.106) in EC. The Lynch syndrome subgroup had 22.907% pooled D-MMR (95% CI, 14.852 to 32.116). D-MMR was highest in type I EC (25.810) (95% CI, 22.503 to 29.261) compared to type II (13.736) (95% CI, 8.392 to 20.144). Pooled D-MMR was highest at EC stage and grades I–II (79.430% and 65.718%, respectively) and lowest in stages III–IV and grade III (20.168% and 21.529%). The pooled odd ratios comparing D-MMR to proficient MMR favored low-stage EC disease (1.565; 0.894 to 2.740), lymphovascular invasion (1.765; 1.293 to 2.409), and myometrial invasion >50% (1.271; 0.871 to 1.853).
Conclusions
Almost one-quarter of EC patients present with D-MMR tumors. The majority has less aggressive endometrioid histology. D-MMR presents at lower tumor stages compared to MMR-proficient cases in EC. However other metastatic parameters are comparatively higher in the D-MMR disease setting. -
Citations
Citations to this article as recorded by
- Molecular Classification and Clinical Outcomes in Endometrial Cancer: Real-World Evidence from a Tertiary Care Center
Tanadon Salakphet, Prapaporn Suprasert, Tip Pongsuvareeyakul, Chinachote Teerapakpinyo, Surapan Khunamornpong
Cancers.2026; 18(2): 181. CrossRef - Comparison of Molecular Alterations and Survival Analysis in Uterine Endometrioid Carcinomas and Serous Carcinomas: An In Silico Study
Zeynep Sağnak Yılmaz
Archives of Current Medical Research.2026; 7(1): 244. CrossRef - Prevalence of Mismatch Repair Gene Defects by Means of Immuno-histochemistry Staining for MMR Proteins in Endometrial Cancer
Kaustubh Girish Burde, Indu R. Nair, Pavithran Keechilattu, Anupama Rajanbabu
The Journal of Obstetrics and Gynecology of India.2025; 75(S1): 135. CrossRef - Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors
Joy A. Awosika, James L. Gulley, Danielle M. Pastor
International Journal of Molecular Sciences.2025; 26(9): 4394. CrossRef - Changes in Nucleolar Activity Under Conditions of Microsatellite Instability in the Uterine Mucosa in Precancer and Endometrial Cancer
A. V. Zatvornickaya, E. L. Kazachkov, E. A. Kazachkova
Ural Medical Journal.2025; 24(2): 71. CrossRef - Current approaches to first-line therapy for endometrial cancer: the role of lenvatinib and pembrolizumab combination therapy
V. M. Nechushkina, S. V. Khokhlova, D. A. Nosov, E. A. Ulrikh, L. A. Kolomiets, A. A. Rumyantsev, G. A. Raskin
Tumors of female reproductive system.2025; 21(2): 127. CrossRef - Endometrial carcinoma in Kenya: clinical and biomarker profiles of 123 cases seen at two tertiary referral centers
Olivia Chesikaw, Allan Njau, Erick Chesori, Khadija Warfa, Anisa Mburu, Afrin Fatima Shaffi, Natalie Banet, Jonathan Wawire
Frontiers in Medicine.2025;[Epub] CrossRef - Association Between MMR Status and Prognostic Pathological Factors in Endometrioid Endometrial Cancer—A Single-Center Retrospective Study
Cezary Miedziarek, Hubert Bochyński, Katarzyna Bociańska, Michał Potograbski, Piotr Tyburski, Mikołaj Piotr Zaborowski, Ewa Nowak-Markwitz
Cancers.2025; 17(22): 3605. CrossRef - Mismatch Repair Deficiency Profiling and Its Impact on Management and Prognosis in Endometrial Cancer Patients: A Comprehensive Update
Emmanouela-Aliki Almperi, Chrysoula Margioula-Siarkou, Aristarchos Almperis, Georgia Margioula-Siarkou, Stefanos Flindris, Alexandros I Daponte, Theodora Papamitsou, Konstantinos Dinas, Stamatios Petousis
Cureus.2025;[Epub] CrossRef - Mismatch Repair Deficiency as a Predictor of Lymph Node Metastasis in Endometrioid Endometrial Carcinoma
Esra Keles, Mustafa Maraşlı, Meziha Taşyürek Coşkun, Elif Ünlügedik Sayın, Öncel İpekçi, Mervernur Şahin, Fatih Şanlıkan, Uğur Kemal Öztürk, İsmail Bağlar, Sahra Sultan Kara, Melis Hazırlar
Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi.2025; 12(3): 269. CrossRef - Guidelines of the Brazilian Society of Surgical Oncology for anatomopathological, immunohistochemical, and molecular testing in female tumors
Reitan Ribeiro, Filomena Marino Carvalho, Glauco Baiocchi, Rodrigo Santa Cruz Guindalini, Juliano Rodrigues da Cunha, Carlos Henrique dos Anjos, Caroline de Nadai Costa, Ana Carolina Leite Vieira Costa Gifoni, Renato Cagnacci Neto, Allyne Queiroz Carneiro
Journal of Surgical Oncology.2024; 130(4): 882. CrossRef - Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
А. E. Protasova, G. A. Raskin, M. S. Sobivchak
Tumors of female reproductive system.2024; 20(2): 105. CrossRef - Refining of cancer-specific genes in microsatellite-unstable colon and endometrial cancers using modified partial least square discriminant analysis
Woong Na, Sung Hak Lee, Seunghee Lee, Jong-Seok Kim, Seung Yun Han, Yong Min Kim, Mihye Kwon, Young Soo Song
Medicine.2024; 103(52): e41134. CrossRef - Cancer-specific functional profiling in microsatellite-unstable (MSI) colon and endometrial cancers using combined differentially expressed genes and biclustering analysis
Woong Na, Il Ju Lee, Insong Koh, Mihye Kwon, Young Soo Song, Sung Hak Lee
Medicine.2023; 102(19): e33647. CrossRef - Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status
Daniela de Freitas, Fernando Nalesso Aguiar, Cristina Anton, Danielle Cristina de Almeida, Carlos Eduardo Bacchi, Jesus Paula Carvalho, Filomena Marino Carvalho
Heliyon.2023; 9(6): e17495. CrossRef - Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution
Hyun-Hee Koh, Eunhyang Park, Hyun-Soo Kim
Biomedicines.2023; 11(8): 2269. CrossRef - miR-486-3p Controls the Apoptosis of Endometrial Carcinoma Cells
Donghua Wang, Xiaoli Liu, Lirong Cao, Shixiong Gong, Yi He, Xiangbin Jiang, Zhongxian Wang
Journal of Biomaterials and Tissue Engineering.2022; 12(5): 1002. CrossRef - The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
Amelia Favier, Justine Varinot, Catherine Uzan, Alex Duval, Isabelle Brocheriou, Geoffroy Canlorbe
Cancers.2022; 14(15): 3783. CrossRef
- Molecular Classification and Clinical Outcomes in Endometrial Cancer: Real-World Evidence from a Tertiary Care Center
First
Prev
